These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 16128681

  • 1. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A.
    Hepatology; 1997 Jul 01; 26(1):34-9. PubMed ID: 9214449
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul 01; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 4. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S, Kawafune T, Suzuki T, Kubota M, Okajima T, Sumino Y, Akita H.
    Am J Gastroenterol; 1995 May 01; 90(5):788-93. PubMed ID: 7733089
    [Abstract] [Full Text] [Related]

  • 5. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, Mandal SK, Ray S, Dasgupta S.
    Am J Gastroenterol; 2003 Jun 01; 98(6):1371-6. PubMed ID: 12818283
    [Abstract] [Full Text] [Related]

  • 6. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders.
    Berzigotti A, Rinaldi MF, Magalotti D, Morelli MC, Zappoli P, Andreone P, Rossi C, Zoli M.
    J Hepatol; 2006 Feb 01; 44(2):310-6. PubMed ID: 16343679
    [Abstract] [Full Text] [Related]

  • 7. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 01; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 8. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J, Kravetz D, Rodes J.
    Gastroenterology; 1981 Mar 01; 80(3):518-25. PubMed ID: 6108897
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr 01; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May 01; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A.
    J Hepatol; 2010 Jan 01; 52(1):45-53. PubMed ID: 19914730
    [Abstract] [Full Text] [Related]

  • 12. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ.
    J Gastroenterol; 2003 Jan 01; 38(12):1150-4. PubMed ID: 14714252
    [Abstract] [Full Text] [Related]

  • 13. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R, Kravetz D, Fassio E, Ameigeiras B, Garcia D, Isla R, Landeira G, Dominguez N, Romero G, Argonz J, Terg R.
    Hepatology; 2003 Feb 01; 37(2):359-65. PubMed ID: 12540786
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A, Lledó JL, Bañares R, Rossi I, Iborra J, Calleja JL, Garrido A, Escartin P, Bosch J.
    Hepatology; 1994 Sep 01; 20(3):611-7. PubMed ID: 7915703
    [Abstract] [Full Text] [Related]

  • 15. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul 01; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 16. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C, Sacerdoti D, Bolognesi M, Bombonato G, Gatta A.
    J Hepatol; 1998 Apr 01; 28(4):622-30. PubMed ID: 9566831
    [Abstract] [Full Text] [Related]

  • 17. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A.
    Hepatology; 2000 Nov 01; 32(5):930-4. PubMed ID: 11050041
    [Abstract] [Full Text] [Related]

  • 18. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep 01; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 19. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Lee SS.
    Am J Gastroenterol; 2005 Mar 01; 100(3):631-5. PubMed ID: 15743362
    [Abstract] [Full Text] [Related]

  • 20. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J.
    J Hepatol; 2004 May 01; 40(5):757-65. PubMed ID: 15094222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.